Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of treprostinil to treat and prevent ischemic lesions

Use of treprostinil to treat and prevent ischemic lesions

US Patent 8765813 · Granted Jul 1, 2014

Estimated economic value: $40,400,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medical body shield2025
Dry powder treprostinil for the treatment of pulmonary hypertension2025
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2025
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2023
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2023
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2023
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2023
Dry powder treprostinil for the treatment of pulmonary hypertension2023
Dry powder treprostinil for the treatment of pulmonary hypertension2023